The Effects of Methylphenidate on Ventricular Repolarization Parameters in Children with Attention-Deficit Hyperactivity Disorder

被引:4
作者
Tanir, Yasar [1 ]
Erbay, Muhammed Furkan [1 ]
Ozkan, Selcuk [2 ]
Ozdemir, Rahmi [3 ]
Orengul, Abdurrahman Cahid [1 ]
机构
[1] Istanbul Univ, Istanbul Med Fac, Dept Child & Adolescent Psychiat, Istanbul, Turkiye
[2] Kutahya Hlth Sci Univ, Evliya Celebi Training & Res Hosp, Dept Child & Adolescent Psychiat, Kutahya, Turkiye
[3] Kutahya Hlth Sci Univ, Evliya Celebi Training & Res Hosp, Dept Pediat Cardiol, Kutahya, Turkiye
来源
ALPHA PSYCHIATRY | 2023年 / 24卷 / 05期
关键词
Attention-deficit hyperactivity disorder; cardiovascular effects; electrocardiog-raphy; methylphenidate; children; T-END INTERVAL; DEFICIT/HYPERACTIVITY DISORDER; RELEASE METHYLPHENIDATE; RISK; RISPERIDONE; ADHD; PEAK; ADOLESCENTS; DISPERSION; THERAPY;
D O I
10.5152/alphapsychiatry.2023.231185
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Long-acting methylphenidate (MPH), a psychostimulant agent, is widely used in the treatment of attention-deficit hyperactivity disorder (ADHD). Methylphenidate might cause an increment in the risk of lethal arrhythmias by deteriorating ventricular repolarization. QT intervals, the corrected QT (QTc), QT dispersion, T-peak to T-end (TpTe), and the TpTe/QTc ratio are the most utilized indicators of ventricular repolarization in electrocardiogram (ECG). The present study was conducted to examine the effects of long-term MPH use on the ECG in pediatric patients.Methods: A total of 52 children with ADHD and 51 age- and gender-matched controls were enrolled in the study. The children had been using MPH regularly for at least 6 months. Comparisons were made regarding ECG parameters, including the mean intervals of QT, QTc, QTc dispersion interval duration, TpTe intervals, TpTe/QT, and TpTe/QTc ratio.Results: The median duration of treatment with MPH was 30 months (minimum-maximum: 6-120), and the median MPH dose was 30 mg/day (minimum-maximum: 18-54). The main findings showed significantly prolonged P-wave dispersion, TpTe interval, TpTe dispersion, and TpTe/QT and TpTe/QTc ratios in the ADHD group compared to the healthy controls (P < .001). These parameters were not associated with MPH dose or treatment duration. Additionally, nearly half of the patients had QTc values of 460 ms or higher, but there were no significant differences in treatment duration and dose compared to the remaining group (P = .792 and P = .126).Conclusion: Methylphenidate may have proarrhythmogenic effects in children with ADHD, which may not be adversely affected by long-term use and treatment dose. Considering the extensive use of MPH, cardiac monitoring of these children is important.
引用
收藏
页数:66
相关论文
共 31 条
  • [1] Tpeak-Tend and Tpeak-Tend/QT Ratio as Markers of Ventricular Arrhythmia Risk in Cardiac Resynchronization Therapy Patients
    Barbhaiya, Chirag
    Po, Jose Ricardo F.
    Hanon, Sam
    Schweitzer, Paul
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2013, 36 (01): : 103 - 108
  • [2] Bazett HC, 1920, HEART-J STUD CIRC, V7, P353
  • [3] Tpeak-Tend Interval in 12-Lead Electrocardiogram of Healthy Children and Adolescents Tpeak-Tend Interval in Childhood
    Bieganowska, Katarzyna
    Sawicka-Parobczyk, Malgorzata
    Bieganowski, Maciej
    Piskorski, Jaroslaw
    [J]. ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2013, 18 (04) : 344 - 351
  • [4] Safety of medicines used for ADHD in children: a review of published prospective clinical trials
    Clavenna, Antonio
    Bonati, Maurizio
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (09) : 866 - 872
  • [5] Conners C K, 2002, J Atten Disord, V6 Suppl 1, pS17
  • [6] Dabrowski A, 2000, CIRCULATION, V101, P1693
  • [7] Cardiovascular Safety of Stimulants in Children with Attention-Deficit/Hyperactivity Disorder: A Nationwide Prospective Cohort Study
    Dalsgaard, Soren
    Kvist, Anette Primdal
    Leckman, James F.
    Nielsen, Helena Skyt
    Simonsen, Marianne
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (06) : 302 - 310
  • [8] Attention-deficit/hyperactivity disorder
    Faraone, Stephen V.
    Asherson, Philip
    Banaschewski, Tobias
    Biederman, Joseph
    Buitelaar, Jan K.
    Ramos-Quiroga, Josep Antoni
    Rohde, Luis Augusto
    Sonuga-Barke, Edmund J. S.
    Tannock, Rosemary
    Franke, Barbara
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [9] Risk of Cardiovascular Morbidity With Risperidone or Paliperidone Treatment Analysis of 64 Randomized, Double-Blind Trials
    Gopal, Srihari
    Hough, David
    Karcher, Keith
    Nuamah, Isaac
    Palumbo, Joseph
    Berlin, Jesse A.
    Baseman, Alan
    Xu, Yimei
    Kent, Justine
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (02) : 157 - 161
  • [10] Greenhill L, 2002, J Atten Disord, V6 Suppl 1, pS89